* U.S. Food and Drug Administration Approves Sotyktu™ (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis Bristol-Myers Squibb
* BMS's deucravacitinib approved for plaque psoriasis FiercePharma
* FDA approves new drug for plaque psoriasis treatment Medical News Today
* New Drug OK'd for Treatment of Plaque Psoriasis Healthline
* Deucravacitinib Receives FDA Approval for Moderate-to-Severe Plaque Psoriasis Rheumatology Network
* View Full Coverage on Google News
http://dlvr.it/SY6qLz
http://dlvr.it/SY6qLz